Th1/Th2 cross regulation.

We present and analyze a model for the cross-regulation of the Th1 and Th2 helper cell subsets during an immune response by the regulatory cytokines interferon-gamma (IFN)-gamma) and interleukin-10 (IL-10). IFN-gamma, secreted by Th1 cells, can inhibit the proliferation of Th2 cells. Interleukin-10, secreted by Th2 cells, inhibits cytokine production by Th1 cells. Based on these properties, the model shows that responses are expected to be dominated by either Th1 cells or Th2 cells but not both. Which type dominates is shown to depend principally on the relative efficiencies of activation of the responding Th1 and Th2 cells. However, our model, as well as numerous experiments, show that perturbations of the system allow one to switch from a Th2 to a Th1 response, or vice versa. Our model can account for observed outcomes of parasitic infection and may also contribute to our understanding of immune responses to HIV infection as well as to tolerance to self components. It also predicts that in certain parameter ranges vaccination with low doses of live parasites can provide protection against subsequent encounters with high doses that normally induce disease. Experiments by Bretscher et al. (1992, Science 257, 539) on Leishmania major infection are consistent with this prediction. A similar strategy may also be relevant for the design of an AIDS vaccine. Lastly, our results indicate that Th1/Th2 cross-regulation is capable of generating a "sneaking through" phenomenon, and hence it may play a role in tumor immunity.

[1]  S. Buus,et al.  Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas. , 1992, Journal of immunology.

[2]  T. Mosmann,et al.  Functional diversity of T lymphocytes due to secretion of different cytokine patterns , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  V. Nussenzweig,et al.  γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites , 1987, Nature.

[4]  S. Romagnani Human TH1 and TH2 subsets: doubt no more. , 1991, Immunology today.

[5]  P. De Baetselier,et al.  Preferential activation of Th2 cells in chronic graft-versus-host reaction. , 1993, Journal of immunology.

[6]  Andreas Radbruch,et al.  Immunoglobulin class switching: molecular and cellular analysis. , 1990, Annual review of immunology.

[7]  B. Dutia,et al.  Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage , 1989, The Journal of experimental medicine.

[8]  K. Else,et al.  Modulation of cytokine production and response phenotypes in murine trichuriasis , 1992, Parasite immunology.

[9]  D. Gray,et al.  B-cell memory is short-lived in the absence of antigen. , 1991, Nature.

[10]  S. N. Vogel,et al.  Silica enhancement of murine endotoxin sensitivity , 1982, Infection and immunity.

[11]  M. Sykes,et al.  IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity. , 1993, Journal of immunology.

[12]  A. Zlotnik,et al.  IL-10: a novel cytotoxic T cell differentiation factor. , 1991, Journal of immunology.

[13]  A. Sher,et al.  IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. , 1992, Journal of immunology.

[14]  R. Steinman,et al.  An antigen-independent contact mechanism as an early step in T cell- proliferative responses to dendritic cells , 1989, The Journal of experimental medicine.

[15]  T. Mosmann,et al.  Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. , 1987, Journal of immunology.

[16]  C. Janeway,et al.  Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma , 1993, The Journal of experimental medicine.

[17]  J. McKenzie,et al.  Interstitial dendritic cells. , 1990, International reviews of immunology.

[18]  S. Russell,et al.  Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. , 1983, Journal of immunology.

[19]  Bayesian Rcvr,et al.  I I I I I I I I I , 1972 .

[20]  G. F. Burton,et al.  Follicular Dendritic Cells as Accessory Cells , 1990, Immunological reviews.

[21]  H. Bielefeldt-Ohmann,et al.  Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. , 1992, Science.

[22]  M. Clerici,et al.  A strategy for prophylactic vaccination against HIV. , 1993, Science.

[23]  D. Mason,et al.  Subsets of CD4+ T Cells and their Roles in the Induction and Prevention of Autoimmunity , 1991, Immunological reviews.

[24]  A. Jayawardena Immune responses in malaria , 1981 .

[25]  I. Cohen Regulation of Autoimmune Disease Physiological and Therapeutic , 1986, Immunological reviews.

[26]  A. Woods,et al.  Cloned, Ia-restricted T cells that do not produce interleukin 4(IL 4)/B cell stimulatory factor 1(BSF-1) fail to help antigen-specific B cells. , 1987, Journal of immunology.

[27]  R. Steinman,et al.  Antigen-specific T lymphocytes efficiently cluster with dendritic cells in the human primary mixed-leukocyte reaction. , 1988, Cellular immunology.

[28]  R. Fernandez-Botran,et al.  Cellular interactions in the humoral immune response. , 1989, Advances in immunology.

[29]  F. Breedveld,et al.  T Cells Cloned from Human Rheumatoid Synovial Membrane Functionally Represent the Th 1 Subset , 1992, Scandinavian Journal of Immunology.

[30]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[31]  A. Abbas,et al.  Inhibition of B lymphocyte activation by interferon-gamma. , 1987, Journal of immunology.

[32]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[33]  R. Fernandez-Botran,et al.  Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells , 1988, The Journal of experimental medicine.

[34]  P. Greenberg Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. , 1991, Advances in immunology.